Journal for ImmunoTherapy of Cancer (Nov 2021)

768 Systemic delivery of a tumor-targeted TLR9 agonist conjugate transforms the tumor immune landscape and induces tumor regression in mice

  • Idit Sagiv-Barfi,
  • Ronald Levy,
  • Caitlyn Miller Candidate,
  • Patrick Neuhoefer,
  • Debra Czerwinski,
  • Steven Artandi,
  • Carolyn Bertozzi,
  • Jennifer Cochran

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.768
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.